23,093.37
+158.69
(+0.69%)
3,690.48
+32.45
(+0.887%)
4,105.33
+69.03
(+1.710%)
11,673.83
+316.51
(+2.787%)
80,658.0000
-531.4400
(-0.655%)
22/01/2025 11:26
大行報告 | 蔚小理、藥明系、電訊股、比亞迪及領展最新評級/目標價,一表盡掌握
.高盛點評蔚小理,降理想(02015)、蔚來(09866)目標卻升小鵬(09868)目標
.高盛調升藥明系目標價,其中藥明康德(02359)目標由58元升至62.4元
.大摩看好中資電訊股,皆維持超配評級



1069,,新聞,專題透視,reports